Sanofi/GSK restart COVID-19 vaccine trials after tweaking formulation
pharmaphorum
FEBRUARY 22, 2021
Sanofi and GlaxoSmithKline are restarting clinical development of their COVID-19 vaccine, which was delayed after hitting a snag late last year. But instead rivals such as BioNTech/Pfizer, AstraZeneca and Moderna have made it to market first with their vaccines.
89 
Let's personalize your content